Contact
searchSearch
HMP Global

News

News
Mobile Opioid Treatment Units Enhance Methadone Availability in Rural Areas
01/18/2024
Mobile opioid treatment program units increase access to methadone for opioid use disorder and are the most impactful in rural areas, according to a study published in Health Services Research.
Mobile opioid treatment program units increase access to methadone for opioid use disorder and are the most impactful in rural areas, according to a study published in Health Services Research.
Mobile opioid treatment program...
01/18/2024
Pharmacy Learning Network
News
Physicians Concerned Weight Loss Drugs May Perpetuate Inequities
01/18/2024
Some physicians are concerned that high demand and prices for high-profile obesity drugs are keeping them out of reach for many who need them, according to a recent Reuters report.
Some physicians are concerned that high demand and prices for high-profile obesity drugs are keeping them out of reach for many who need them, according to a recent Reuters report.
Some physicians are concerned...
01/18/2024
Pharmacy Learning Network
News
Complex Dynamics of the Respiratory Syncytial Virus (RSV) Surge
01/18/2024
Nonviral factors may have also contributed to the surge, including changes in population immunity due to altered RSV dynamics resulting from interventions during the COVID-19 pandemic.
Nonviral factors may have also contributed to the surge, including changes in population immunity due to altered RSV dynamics resulting from interventions during the COVID-19 pandemic.
Nonviral factors may have also...
01/18/2024
Pharmacy Learning Network
News
Seizure Med Under Class I Recall
01/17/2024
A Class I recall has been issued for a single lot of the anticonvulsant vigabatrin for oral solution because of a potential for powder to leak from product pouches and subsequent underdosing, according to the January 17, 2024, US Food and...
A Class I recall has been issued for a single lot of the anticonvulsant vigabatrin for oral solution because of a potential for powder to leak from product pouches and subsequent underdosing, according to the January 17, 2024, US Food and...
A Class I recall has been issued...
01/17/2024
Pharmacy Learning Network
News
Drug Approvals Up in 2023
01/15/2024
The US Food and Drug Administration (FDA) approved 18 more novel drugs in 2023 than it did the previous year. New drug approvals totaled 55 in 2023, compared with just 37 in 2022 and 51 in 2021, according to a Reuters report. The FDA...
The US Food and Drug Administration (FDA) approved 18 more novel drugs in 2023 than it did the previous year. New drug approvals totaled 55 in 2023, compared with just 37 in 2022 and 51 in 2021, according to a Reuters report. The FDA...
The US Food and Drug...
01/15/2024
Pharmacy Learning Network
News
RSV Can Infect Nerve Cells, Triggering Damage
01/15/2024
“Until this study, the theory was that the inflammatory response was indirectly activating the nerves,” said study corresponding author Giovanni Piedimonte, MD, FAAP, FCCP, vice president for research and professor of pediatrics,...
“Until this study, the theory was that the inflammatory response was indirectly activating the nerves,” said study corresponding author Giovanni Piedimonte, MD, FAAP, FCCP, vice president for research and professor of pediatrics,...
“Until this study, the theory...
01/15/2024
Pharmacy Learning Network
News
FDA Approves Temporary Importation of Syphilis Drug Amidst Ongoing Treatment Shortage
01/12/2024
The FDA has approved the temporary importation of a syphilis drug from a French company to address the shortage of the recommended treatment in the US, which has put pregnant women and their families at risk during the syphilis crisis.
The FDA has approved the temporary importation of a syphilis drug from a French company to address the shortage of the recommended treatment in the US, which has put pregnant women and their families at risk during the syphilis crisis.
The FDA has approved the...
01/12/2024
Pharmacy Learning Network
News
Epilepsy, Migraine Drug Recalled
01/12/2024
Azurity Pharmaceuticals Inc. is recalling 2220 bottles of Eprontia oral solution. According to the January 10, 2024, US Food and Drug Administration (FDA) Enforcement Report, samples of the drug tested out of specification for an impurity...
Azurity Pharmaceuticals Inc. is recalling 2220 bottles of Eprontia oral solution. According to the January 10, 2024, US Food and Drug Administration (FDA) Enforcement Report, samples of the drug tested out of specification for an impurity...
Azurity Pharmaceuticals Inc. is...
01/12/2024
Pharmacy Learning Network
News
Sterility Concerns Prompt Dialysis Solution Recall
01/12/2024
Fresenius Medical Care Holdings Inc. is recalling 69,590 bags of Delflex peritoneal dialysis solution because of sterility concerns, according to the January 10, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Fresenius Medical Care Holdings Inc. is recalling 69,590 bags of Delflex peritoneal dialysis solution because of sterility concerns, according to the January 10, 2024, US Food and Drug Administration (FDA) Enforcement Report.
Fresenius Medical Care Holdings...
01/12/2024
Pharmacy Learning Network
News
Association of Major Depression With Oral Contraceptive Pill Use
01/11/2024
Women who take oral contraceptive pills (OCP) have a lower prevalence of major depression when compared with former users and those who have never used OCP, according to a recent cross-sectional study.
Women who take oral contraceptive pills (OCP) have a lower prevalence of major depression when compared with former users and those who have never used OCP, according to a recent cross-sectional study.
Women who take oral...
01/11/2024
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use